Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apogee Therapeutics

40.12
+0.92002.35%
Post-market: 40.120.00000.00%16:05 EDT
Volume:616.31K
Turnover:24.89M
Market Cap:2.33B
PE:-12.16
High:41.05
Open:39.90
Low:39.24
Close:39.20
Loading ...
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Correspondence

Form CORRESP - Correspondence
Mar 06, 2024

Correspondence

Form CORRESP - Correspondence
Mar 05, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 28, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 28, 2023

Major Issues Report

Form 8-K - Current report
Aug 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 28, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jul 24, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals